Roles of Ceramides in Non-Alcoholic Fatty Liver Disease - Sorbonne Université
Journal Articles Journal of Clinical Medicine Year : 2021

Roles of Ceramides in Non-Alcoholic Fatty Liver Disease

Abstract

Non-alcoholic fatty liver disease is one of the most common chronic liver diseases, ranging from simple steatosis to steatohepatitis, fibrosis, and cirrhosis. Its prevalence is rapidly increasing and presently affects around 25% of the general population of Western countries, due to the obesity epidemic. Liver fat accumulation induces the synthesis of specific lipid species and particularly ceramides, a sphingolipid. In turn, ceramides have deleterious effects on hepatic metabolism, a phenomenon called lipotoxicity. We review here the evidence showing the role of ceramides in non-alcoholic fatty liver disease and the mechanisms underlying their effects.
Fichier principal
Vignette du fichier
jcm-10-00792-v2.pdf (1.54 Mo) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-03163597 , version 1 (09-03-2021)

Identifiers

Cite

Eric Hajduch, Floriane Lachkar, Pascal Ferré, Fabienne Foufelle. Roles of Ceramides in Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine, 2021, 10 (4), pp.792. ⟨10.3390/jcm10040792⟩. ⟨hal-03163597⟩
61 View
90 Download

Altmetric

Share

More